Important legal notice
Contact   |   Search on Europa   

Infectious Diseases Graphic element print icon Graphic element
  Homepage
Graphic element General information
  RTD Infectious Diseases Unit
  Developing countries
  EDCTP
   
Graphic element Projects
  About FP6 Funding
  FP6 projects
  About FP5 Funding
  FP5 projects
   
   
Graphic element Addressed Diseases
  HIV/AIDS
- News
  Malaria
  Tuberculosis
   
Graphic element Calls for proposals
  FP7 Calls
   
Graphic element Contact corner
  Unit
  Scientific officers
  Subscribe to our mailing list
   
 
EDCTP
TUBERCULOSIS
Framework programme: 5
Project number:
QLK2-CT-2002-30198
EC contribution: € 1 240 000
Duration: 12 months
Type: AM
Starting date: 1 August 2002
Graphic element European and Developing Countries Clinical Trials Programme
Keywords: Life sciences; medicine; health; safety; scientific research; social aspects

Summary:

The objective of this Accompanying Measure is to create the European Clinical Trials Platform for Poverty Related Diseases (ECTP). This will be achieved by a systematic analysis of the proposed functions and operational structure of the ECTP, based on Article 169 of the Treaty of Rome. This analysis will be also based on information regarding EU National Programmes, other European and DC initiatives, and extensive consultations with the stakeholders. The ultimate goal of the future ECTP will be that new vaccines, drugs and health interventions could be properly and efficiently tested for safety, efficacy and effectiveness, and finally delivered faster in an improved health system to the needy populations. The ECTP must be driven by the needs of DCs. Its main operational goal will be to accelerate the development and evaluation of effective interventions against diseases linked to poverty.
The objective of this accompanying measure is to create the European Clinical Trials Platform (ECTP) for poverty related diseases (PRD), which will provide a new service for the EU research community, and add value and coherence to national R&D activities. The ultimate goal is that new vaccines, drugs and health interventions can be properly and efficiently tested for safety, efficacy and effectiveness, and delivered faster in an improved health system to the needy populations. The ECTP will be driven by the needs of developing countries. Its main operational goal will be to accelerate the development and evaluation of effective interventions against PRDs.
The four main agreed functions of the ECTP will be:
1) strengthening the capacity to conduct clinical trials under good clinical practice (GCP) in developing countries
2) networking relevant activities in EU Member States
3) initiating and arranging the design and conduct of PRD clinical trials
4) supporting the external and public relations of its activities

Coordinator:

Antoni Trilla
Hospital Clinic Barcelona
Assessment, Support and Prevention
Villaroel 170
08036 Barcelona
Spain
Tel: +34 93 227 5754
Fax: +34 93 451 5272
E-mail: atrilla@clinic.ub.es

Partners:

Principal
Scientific
Participants
Official Address Other Information
2Don BruntonMedical Research Council (MRC)
London, UK
3Kristen HauglandUniversity of Bergen, Centre for International Health - Faculty of Medicine
Bergen, Norway
4Bruno GryseelsPrince Leopold Institute of Tropical Medicine
Antwerp, Belgium
5Enrico GaraciIstituto Superiore di Sanita, Virology Laboratory
Rome, Italy
6Michael DermitzakisNational and Kapodistrian University of Athens, Infectious Diseases and Antimicrobial Chemotherapy Research Laboratory Medical School
Athens, Greece
7Hans-Georg EichlevVienna School of Clinical Research
Vienna, Austria
8Jean CastexInstitut Pasteur, Direction des Affaires Internationales
Paris, France

 
 
top
Graphic element